CB2R-IN-1;Methanesulfonamide, 1,1,1-trifluoro-N-[[4-propyl-1-[[1-(2-pyridinylsulfonyl)-1H-indol-2-yl]sulfonyl]-4-piperidinyl]methyl]-;CB-2R-IN-1,CB2RIN1,CB2R IN 1
CB2R-IN-1 is a potent cannabinoid CB2 receptor inverse agonist with high selectivity over the CB1 receptor, used for studying CB2 receptor-mediated biological processes and potential therapeutic applications in conditions involving the endocannabinoid system.